Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for use as Second-line Therapy in Adults in Patients with R/R DLBCL.
Thursday, November 3, 2022 at 6pm
Featured Speaker:
Karolina Faysman, AOCNP, DNP-C
UCLA Medical Center
Los Angeles, CA
Location:
Bob's Steakhouse
555 S Lamar St
Dallas, TX 75202
Resister: http://sphase.info/inc9943
To register manually, please contact your MorphoSys-Incyte representative:
Carla Simmons at 972-997-1709 or csimmons@incyte.com with the following information: name, title/degree, state(s) and state license #(s), affiliation, address, phone, and email. Appropriate attendees include licensed HCPs with a direct role in patient care. Due to change in policy, MorphoSys-Incyte will no longer provide or pay for alcohol at speaker programs.
This is not a chapter meeting.Monjuvi_Dinner_11_3_22_invite.pdf